STRUCTURAL HEART
SAPIEN 3 TAVR (23mm) Valve via Percutaneous Femoral Access – Oct 2016

A 89 year-old male presented with worsening dyspnea on exertion– NYHA class III and fatigue, with history of hypertension, hyperlipidemia and multiple prior PCIs. Patient also suffers from mild cognitive impairment as a result of childhood meningitis. TTE revealed severe valvular aortic stenosis; peak gradient = 88 mmHg, mean gradient = 58 mmHg, Doppler valve area = 0.66cm2, Ao peak velocity = 4.7m/sec and LVEF of 63 %. Cardiac cath showed non-obstructive CAD with patent stents. CT angiogram revealed minimum diameters of 10.5mm for bilateral common iliac arteries and aortic annulus of 25.2 X 21.3 mm (average 23.2mm) with an area of 410mm2. The STS mortality risk for Surgical AVR is 1.5% and the Logistic Euroscore mortality risk is 11.3%. Patient was determined to be intermediate risk for SAVR due to age and neurological dysfunction and is now planned for TAVR with Edwards Sapien 3 (23 mm) valve via percutaneous femoral access under conscious sedation.

49:24

comments

Leave Your Comments

suggestion
Suggestions
Valve-in-Valve TAVR with 26mm SAPIEN-3 – March 2019
Views235

79 year old man presents with worsening exertional dyspnea (NYHA Class III) for the last 3 months. Patient has required […]


50:31
Valve-in-Valve TAVR with 29mm Evolut-R CoreValve – January 2019
Views464

79 year old man presents with progressive exertional dyspnea (NYHA Class III) for the last 2 months.


1:07:06
TAVR 29mm Sapien-3 – November 2018
Tags:
Views667

96 year old male presents with progressive exertional dyspnea (NYHA Class III) for the last 4 months.


49:42
TAVR in a Patient with Prior Mitral Valve Replacement – September 2018
Tags: |
Views647

87 year old female presents with progressive exertional dyspnea (NYHA Class III) for the last 3 months.